Viewing Study NCT04946227


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-03-11 @ 7:35 AM
Study NCT ID: NCT04946227
Status: UNKNOWN
Last Update Posted: 2021-06-30
First Post: 2021-03-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2')
Sponsor: Yonsei University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pembrolizumab View
None hypermutated View
None hormone receptor-positive View
None breast cancer View